Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$355M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$304M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Gilead Sciences
GILD
|
+$239M |
| 5 |
Visa
V
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$388M |
| 2 |
Wells Fargo
WFC
|
+$370M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$295M |
| 4 |
Alibaba
BABA
|
+$234M |
| 5 |
IBM
IBM
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.55% |
| 2 | Healthcare | 5.29% |
| 3 | Financials | 4.23% |
| 4 | Communication Services | 3.53% |
| 5 | Energy | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZNGA
4401
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $81K | ﹤0.01% |
40,504
-48,167
| -54% | -$108K |
|
|
INSY
4402
DELISTED
Insys Therapeutics, Inc.
INSY
| $81K | ﹤0.01% |
5,377
+4,329
| +413% | +$82.2K |
|
|
KERX
4403
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $81K | ﹤0.01% |
20,181
+18,957
| +1,549% | +$75.7K |
|
|
XRM
4404
DELISTED
Xerium Technologies Inc (new)
XRM
| $81K | ﹤0.01% |
16,330
+16,276
| +30,141% | +$132K |
|
|
LNCE
4405
PUT
DELISTED
Snyders-Lance, Inc.
LNCE
| $81K | ﹤0.01% |
+2,618
| New | +$83.8K |
|
4406
PUT
Boyd Gaming
BYD
$5.92B
| $80K | ﹤0.01% |
4,000
-900
| -18% | -$15.9K |
|
4407
Kearny Financial
KRNY
$595M
| $80K | ﹤0.01% |
6,700
-19,200
| -74% | -$230K |
|
|
CPLA
4408
DELISTED
Capella Education Company
CPLA
| $80K | ﹤0.01% |
1,544
+503
| +48% | +$23.3K |
|
4409
Melco Resorts & Entertainment
MLCO
$2.12B
| $79K | ﹤0.01% |
4,971
-58,318
| -92% | -$885K |
|
4410
CALL
ProShares Ultra Technology
ROM
$1.27B
| $79K | ﹤0.01% |
16,000
+14,400
| +900% | +$62.2K |
|
4411
Sonic Automotive
SAH
$2.53B
| $79K | ﹤0.01% |
+4,444
| New | +$81.4K |
|
|
TAST
4412
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $79K | ﹤0.01% |
+5,619
| New | +$73.3K |
|
|
SNR
4413
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $79K | ﹤0.01% |
7,918
-275
| -3% | -$2.58K |
|
|
CUDA
4414
DELISTED
Barracuda Networks, Inc.
CUDA
| $79K | ﹤0.01% |
5,250
+5,143
| +4,807% | +$65.5K |
|
|
CSR
4415
Centerspace
CSR
$926M
| $78K | ﹤0.01% |
1,114
-247
| -18% | -$16.2K |
|
4416
Encompass Health
EHC
$12.5B
| $78K | ﹤0.01% |
2,665
+2,152
| +419% | +$59.4K |
|
4417
First Financial Bankshares
FFIN
$4.93B
| $78K | ﹤0.01% |
+5,400
| New | +$74.1K |
|
4418
CALL
Monro
MNRO
$368M
| $78K | ﹤0.01% |
1,100
+1,000
| +1,000% | +$66.2K |
|
|
BLOX
4419
PUT
DELISTED
Infoblox Inc
BLOX
| $78K | ﹤0.01% |
4,600
-8,500
| -65% | -$136K |
|
|
STRZA
4420
CALL
DELISTED
Starz - Series A
STRZA
| $78K | ﹤0.01% |
3,000
-2,900
| -49% | -$79.4K |
|
4421
Chemours
CC
$2.2B
| $77K | ﹤0.01% |
11,102
-15,858
| -59% | -$79.7K |
|
4422
CALL
Calumet Specialty Products
CLMT
$3.96B
| $77K | ﹤0.01% |
7,000
+6,900
| +6,900% | +$96K |
|
4423
PUT
Compass Minerals
CMP
$1.13B
| $77K | ﹤0.01% |
1,100
+400
| +57% | +$28.6K |
|
4424
PUT
Flowers Foods
FLO
$1.51B
| $77K | ﹤0.01% |
4,300
+4,200
| +4,200% | +$79.6K |
|
4425
Douglas Dynamics
PLOW
$984M
| $77K | ﹤0.01% |
+3,483
| New | +$70K |
|
Similar funds
Barclays's Q1 2016 Portfolio in Review
As of Q1 2016, Barclays held 6,944 positions worth $65.6B, down 20% from $82.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays withdrew a net $15.2B in Q1 2016, closing 588 positions and reducing 2,924 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $295M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR S&P Pharmaceuticals ETF worth $26M.
- Barclays's largest Q1 2016 buy was State Street SPDR S&P Pharmaceuticals ETF: 650,000 shares worth $26M.
- Barclays added most to KLA in Q1 2016, an estimated $355M increase.
- Barclays's biggest Q1 2016 reduction was Apple, cutting an estimated $388M.
- Barclays fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $295M.
- Barclays's ten largest holdings make up 29% of its $65.6B portfolio in Q1 2016.
- Barclays opened 766 new positions and closed 588 in Q1 2016.
- Barclays's portfolio value fell 20% quarter-over-quarter to $65.6B.
Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.